The consistent manifestation of hypo-m6A in human ALS iPSC~MNs, together with our ChAT-Cre; Mettl14floxed mice recapitulating ALS pathology, prompted us to explore if bolstering the m6A reservoir could represent a therapeutic strategy. Here, CHAT is linked to amyotrophic lateral sclerosis.